Evidence for impaired cortical inhibition in schizophrenia using transcranial magnetic stimulation

Archives of General Psychiatry
Z Jeff DaskalakisShitij Kapur

Abstract

Cortical inhibition (CI) deficits have been proposed as a pathophysiologic mechanism in schizophrenia. This study employed 3 transcranial magnetic stimulation (TMS) paradigms to assess CI in patients with schizophrenia. Paired-pulse TMS involves stimulating with a lower-intensity pulse a few milliseconds before a higher-intensity pulse, thereby inhibiting the size of the motor evoked potential produced by the higher-intensity pulse. In the cortical silent period paradigm, inhibition is reflected by the silent period duration (ie, the duration of electromyographic activity cessation following a TMS-induced motor evoked potential). Transcallosal inhibition involves stimulation of the contralateral motor cortex several milliseconds prior to stimulation of the ipsilateral motor cortex, inhibiting the size of the motor evoked potential produced by ipsilateral stimulation. We measured CI using these 3 paradigms in 15 unmedicated patients with schizophrenia (14 medication-naive and 1 medication-free for longer than 1 year) (13 were in the transcallosal inhibition paradigm), 15 medicated patients with schizophrenia (11 taking olanzapine, 1 risperidone, 1 quetiapine, 1 methotrimeprazine + perphenazine, 1 quetiapine + loxapine), and 15 h...Continue Reading

Citations

Apr 5, 2014·Indian Journal of Psychological Medicine·Hulegar A AbhishekhBangalore N Gangadhar
Mar 6, 2007·Schizophrenia Bulletin·Perminder S Sachdev
Jun 3, 2009·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·David M Eagleman, Vani Pariyadath
Dec 17, 2010·Journal of Neurophysiology·Andrew M Vahabzadeh-HaghAlexander Rotenberg
Jun 15, 2011·Developmental Neuropsychology·Tony W WilsonDonald C Rojas
Aug 26, 2011·European Archives of Psychiatry and Clinical Neuroscience·Andrea SchmittPeter Falkai
Feb 10, 2012·European Archives of Psychiatry and Clinical Neuroscience·Alkomiet HasanThomas Wobrock
Jun 6, 2012·Journal of Psychiatry & Neuroscience : JPN·Natasha RadhuZafiris J Daskalakis
Nov 30, 2012·Molecular Brain·Frances Fangjia LuZafiris J Daskalakis
May 10, 2003·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Zafiris J DaskalakisRobert Chen
May 17, 2011·Cerebral Cortex·Louis De BeaumontHugo Théoret
Dec 5, 2006·Archives of Physical Medicine and Rehabilitation·Michelle L Harris-Love, Leonardo G Cohen
Mar 7, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Zafiris J DaskalakisPaul B Fitzgerald
Jul 2, 2003·Psychiatry Research·Paul B FitzgeraldJayashri Kulkarni
Mar 10, 2004·Psychiatry Research·Kate E HoyNellie Georgiou-Karistianis
Dec 25, 2012·Psychiatry Research·Hulegar A AbhishekhBangalore N Gangadhar
Jan 23, 2002·Molecular Psychiatry·M MallatV Moura Neto
Oct 7, 2004·Journal of Affective Disorders·Paul B FitzgeraldJayashri Kulkarni
May 10, 2006·Experimental Brain Research·Zafiris J DaskalakisRobert Chen
Mar 15, 2013·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Natasha RadhuZafiris J Daskalakis
Mar 31, 2010·Brain : a Journal of Neurology·Faranak FarzanZafiris J Daskalakis
Dec 28, 2011·International Review of Psychiatry·Paul E CroarkinJon Lee
Jul 28, 2015·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Florence ThibautUNKNOWN WFSBP Task Force on Biological Markers
Dec 3, 2008·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Kate E HoyPaul B Fitzgerald
Jan 21, 2016·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Yiqun P MiAimee J Nelson
Jan 23, 2016·Schizophrenia Research·Alanna C BridgmanTony P George
Dec 3, 2014·Schizophrenia Research·Stephan F Taylor, Ivy F Tso
Oct 2, 2012·Brain Stimulation·Crissa L GugliettiPaul Ritvo
May 23, 2012·Brain Research·Zafiris J DaskalakisPaul B Fitzgerald
Sep 29, 2011·Brain Stimulation·Alkomiet HasanThomas Wobrock
May 17, 2011·Biological Psychiatry·Shawn M McClintockAlvaro Pascual-Leone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here